We are live on
!
Find out more
Cerity Partners Portfolio holdings
AUM
$70.8B
1-Year Est. Return
21.68%
This Fund
S&P 500
This Quarter
Est. Return
+5.11%
1 Year Est. Return
+21.68%
3 Year Est. Return
+64.34%
5 Year Est. Return
+67.23%
10 Year Est. Return
–
AUM
$4.21B
AUM Growth
+$1.09B
(+35%)
Cap. Flow
+$955M
Cap. Flow
% of AUM
22.68%
Top 10 Holdings %
Top 10 Hldgs %
34.29%
Holding
765
New
125
Increased
259
Reduced
265
Closed
72
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$110M |
| 2 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$47.6M |
| 3 |
Apple
AAPL
|
+$45.5M |
| 4 |
Microsoft
MSFT
|
+$37.2M |
| 5 |
Amazon
AMZN
|
+$33.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CMD
Cantel Medical Corporation
CMD
|
+$15.9M |
| 2 |
Caterpillar
CAT
|
+$8.11M |
| 3 |
Golub Capital BDC
GBDC
|
+$7.53M |
| 4 |
Intel
INTC
|
+$6.76M |
| 5 |
iShares Biotechnology ETF
IBB
|
+$6.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.98% |
| 2 | Industrials | 11.87% |
| 3 | Financials | 10.81% |
| 4 | Healthcare | 9.53% |
| 5 | Consumer Discretionary | 6.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Invesco NASDAQ Next Gen 100 ETF
QQQJ
$1.12B
| $251K | 0.01% |
7,889
+712
| +10% | +$23.3K |
|
602
Nuveen Floating Rate Income Fund
JFR
$1.23B
| $250K | 0.01% |
25,904
-6,723
| -21% | -$62.9K |
|
603
Labcorp
LH
$25.7B
| $249K | 0.01% |
1,137
-1,604
| -59% | -$322K |
|
604
Revolve Group
RVLV
$1.91B
| $249K | 0.01% |
+5,547
| New | +$226K |
|
605
Bath & Body Works
BBWI
$4.13B
| $248K | 0.01% |
+4,965
| New | +$204K |
|
606
Vanguard US Value Factor ETF
VFVA
$905M
| $248K | 0.01% |
2,621
| – | – |
|
607
Walker & Dunlop
WD
$1.75B
| $248K | 0.01% |
+2,410
| New | +$234K |
|
608
Weyerhaeuser
WY
$17.6B
| $246K | 0.01% |
6,921
+23
| +0.3% | +$783 |
|
|
BLUE
609
DELISTED
bluebird bio
BLUE
| $243K | 0.01% |
621
+97
| +19% | +$47.8K |
|
610
Clorox
CLX
$12.1B
| $242K | 0.01% |
+1,255
| New | +$242K |
|
611
RB Global
RBA
$21.7B
| $242K | 0.01% |
+4,141
| New | +$243K |
|
612
Corteva
CTVA
$59.9B
| $241K | 0.01% |
+5,166
| New | +$229K |
|
613
White Mountains Insurance
WTM
$5.43B
| $240K | 0.01% |
215
| – | – |
|
614
Albemarle
ALB
$13.4B
| $237K | 0.01% |
1,622
-184
| -10% | -$29.5K |
|
615
Quest Diagnostics
DGX
$26B
| $237K | 0.01% |
1,843
-789
| -30% | -$97.2K |
|
616
JD.com
JD
$42.7B
| $235K | 0.01% |
2,786
+345
| +14% | +$31.6K |
|
617
Brown-Forman Class A
BF.A
$13.5B
| $234K | 0.01% |
+3,675
| New | +$251K |
|
618
Waters Corp
WAT
$37.9B
| $234K | 0.01% |
825
+3
| +0.4% | +$819 |
|
619
Equifax
EFX
$21.9B
| $233K | 0.01% |
1,288
-10
| -0.8% | -$1.77K |
|
620
Alcon
ALC
$33.6B
| $232K | 0.01% |
3,290
-134
| -4% | -$9.49K |
|
621
Genuine Parts
GPC
$17.8B
| $232K | 0.01% |
2,008
-764
| -28% | -$81.3K |
|
622
Fluor
FLR
$6.88B
| $231K | 0.01% |
10,000
| – | – |
|
623
iShares Core MSCI International Developed Markets ETF
IDEV
$31.3B
| $231K | 0.01% |
+3,573
| New | +$228K |
|
624
FlexShares Global Upstream Natural Resources Index Fund
GUNR
$7.15B
| $230K | 0.01% |
6,362
| – | – |
|
625
Colgate-Palmolive
CL
$74.6B
| $227K | 0.01% |
2,885
-21,300
| -88% | -$1.67M |
|
Similar funds
Cerity Partners's Q1 2021 Portfolio in Review
As of Q1 2021, Cerity Partners held 765 positions worth $4.21B, up 35% from $3.12B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Cerity Partners deployed $955M of net new capital in Q1 2021, opening 125 new positions and adding to 259 existing holdings. Its largest new stake was Allogene Therapeutics: 401,602 shares worth $14.2M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Caterpillar, an estimated $8.11M trimmed.
- Cerity Partners's largest Q1 2021 buy was Allogene Therapeutics: 401,602 shares worth $14.2M.
- Cerity Partners added most to State Street SPDR S&P 500 ETF Trust in Q1 2021, an estimated $110M increase.
- Cerity Partners's biggest Q1 2021 reduction was Caterpillar, cutting an estimated $8.11M.
- Cerity Partners fully exited Cantel Medical Corporation in Q1 2021, selling an estimated $15.9M.
- Cerity Partners's ten largest holdings make up 34% of its $4.21B portfolio in Q1 2021.
- Cerity Partners opened 125 new positions and closed 72 in Q1 2021.
- Cerity Partners's portfolio value rose 35% quarter-over-quarter to $4.21B.
Based on Cerity Partners's 13F filing for Q1 2021, filed 12 May 2021.